Ausgabe 6/2023
Inhalt (27 Artikel)
Lymphatic drainage dysfunction is related to clinically significant portal hypertension
Ruixue Ma, Yasuko Iwakiri
Ending stigmatizing language in alcohol and liver disease: a liver societies’ statement
Norah A. Terrault, Graciela Castro-Narro, Aleksander Krag, Shuichiro Shiina
How non-alcoholic fatty liver disease and cirrhosis affect the heart
Søren Møller, Signe Wiese, Mads Barløse, Jens D. Hove
Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis
Yuanyuan Kong, Yameng Sun, Xiaoning Wu, Jialing Zhou, Hao Wang, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, Hongxin Piao, Xiaoyuan Xu, Wei Jiang, Bo Feng, Xiaojuan Ou, Hong You, Samuel S. Lee, Jidong Jia
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection
Anika Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa-Breier, Janina Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding
Zhiying He, Bingqiong Wang, Xiaoning Wu, Zhongjie Hu, Chunqing Zhang, Yanqin Hao, Yongfeng Yang, Yan Huang, Wei Rao, Jing Wang, Jialing Zhou, Shuai Xia, Xiaojuan Ou, Jidong Jia, Hong You
Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis
Yoshiaki Sugiyama, Kenta Yamamoto, Takashi Honda, Asuka Kato, Hisanori Muto, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Tomomi Asano, Atsushi Enomoto, Kei Zaitsu, Masatoshi Ishigami, Mitsuhiro Fujishiro, Hiroki Kawashima
The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI
David Uihwan Lee, Aneesh Bahadur, Reid Ponder, Ki Jung Lee, Gregory Hongyuan Fan, Harrison Chou, Zurabi Lominadze
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort
Jing Zeng, Qian Jin, Jing Yang, Rui-Xu Yang, Rui-Nan Zhang, Jian Zhao, Jian-Gao Fan
Molecular evolution in different subtypes of multifocal hepatocellular carcinoma
Xia Tang, Lei Xiang, Qingshu Li, Yue Shao, Li Wan, Dachun Zhao, Xiaoyuan Li, Songfeng Wu, Haijian Wang, Dewei Li, Keyue Ding
Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression
Qingcan Sun, Mengying Shen, Subin Zhu, Yanxia Liao, Dongyan Zhang, Jingyuan Sun, Zeqin Guo, Leyuan Wu, Lushan Xiao, Li Liu
Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA
Chenhao Zhou, Jialei Weng, Shaoqing Liu, Qiang Zhou, Zhiqiu Hu, Yirui Yin, Peng Lv, Jialei Sun, Hui Li, Yong Yi, Yinghao Shen, Qinghai Ye, Yi Shi, Qiongzhu Dong, Chunxiao Liu, Xiaoqiang Zhu, Ning Ren
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
Kong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, Liu-Ping Luo, Jian-Xi Zhang, Jin-Hong Chen, Kui Wang, Sheng Tai, Zhi-Bo Zhang, Shi-feng Wang, Jin-Yu Zhang, Wu-Yi You, Bin Wang, Peng-Hui You, Ke-Can Lin, Tian Yang, Yong-Yi Zeng
Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression
Yi Xu, Yue Yao, Liang Yu, Hiu Ling Fung, Alexander Hin Ning Tang, Irene Oi-Lin Ng, Melody Y. M. Wong, Chi-Ming Che, Jing Ping Yun, Yunfu Cui, Judy Wai Ping Yam
MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way
Shiji Fang, Liyun Zheng, Xiaoxiao Chen, Xiaoju Guo, Yiming Ding, Ji Ma, Jiayi Ding, Weiqian Chen, Yang Yang, Minjiang Chen, Zhongwei Zhao, Jianfei Tu, Jiansong Ji
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy
Jingzhong Ouyang, Yi Yang, Yanzhao Zhou, Feng Ye, Zhengzheng Wang, Qingjun Li, Ying Xu, Lu Li, Xinming Zhao, Wen Zhang, Aiping Zhou, Zhen Huang, Yong Wang, Jianqiang Cai, Hong Zhao, Jinxue Zhou
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
Benedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, Rafael Paternostro, Philipp Schwabl, Albert Friedrich Stättermayer, Rodrig Marculescu, Matthias Pinter, Peter Quehenberger, Michael Trauner, Morten Karsdal, Ton Lisman, Thomas Reiberger, Diana Julie Leeming, Mattias Mandorfer
3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study
Xiaoqiong Chen, Tao Wang, Zhonghua Ji, Junyang Luo, Weifu Lv, Haifang Wang, Yujie Zhao, Chongyang Duan, Xiangrong Yu, Qiyang Li, Jiawei Zhang, Jinqiang Chen, Xiaoling Zhang, Mingsheng Huang, Shuoling Zhou, Ligong Lu, Meiyan Huang, Sirui Fu
Lymphatic drainage dysfunction via narrowing of the lumen of cisterna chyli and thoracic duct after luminal dilation
Ryo Yano, Masashi Hirooka, Yohei Koizumi, Yoshiko Nakamura, Yusuke Imai, Makoto Morita, Yuki Okazaki, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa
Live donor liver transplantation for pediatric acute liver failure: challenges and outcomes
Viniyendra Pamecha, Nilesh Sadashiv Patil, Sanyam Falari, Nihar Mohapatra, Anubhav Harshit Kumar, Gaurav Sindwani, Neha Garg, Seema Alam, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal
Pure laparoscopic versus open left lateral hepatectomy in pediatric living donor liver transplantation: a review and meta-analysis
Meng Sha, Zhi-peng Zong, Chuan Shen, Jian-jun Zhu, Ming-xuan Feng, Yi Luo, Ying Tong, Qiang Xia
Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
Kevin Tak-Pan Ng, Jiang Liu, Oscar Wai-Ho Yeung, Li Pang, Hoi Chung Shiu, Hui Liu, Xin Xiang Yang, Albert Chi-Yan Chan, Tiffany Cho-Lam Wong, Chung Mau Lo, Kwan Man
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Silke Leonhardt, Christian Jürgensen, Josephine Frohme, Donata Grajecki, Andreas Adler, Michael Sigal, Julia Leonhardt, Julian M. Voll, Jan Matthias Kruse, Roland Körner, Kai-Uwe Eckardt, Hans-Joachim Janssen, Volker Gebhardt, Marc D. Schmittner, Stefan Hippenstiel, Martin Witzenrath, Norbert Suttorp, Elisa T. Helbig, Lena J. Lippert, Paula Stubbemann, Pinkus Tober-Lau, David Hillus, Sascha S. Haenel, Alexandra Horn, Willi M. Koch, Nadine Olk, Mirja Mittermaier, Fridolin Steinbeis, Tilman Lingscheid, Bettina Temmesfeld-Wollbrück, Thomas Zoller, Holger Müller-Redetzky, Alexander Uhrig, Daniel Grund, Christoph Ruwwe-Glösenkamp, Miriam S. Stegemann, Katrin M. Heim, Ralf H. Hübner, Christian Drosten, Victor M. Corman, Bastian Opitz, Martin Möckel, Felix Balzer, Claudia Spies, Steffen Weber-Carstens, Chantip Dang-Heine, Michael Hummel, Georg Schwanitz, Uwe D. Behrens, Maria Rönnefarth, Sein Schmidt, Alexander Krannich, Saskia Zvorc, Jenny Kollek, Christof von Kalle, Jan Doehn, Christoph Tabeling, Linda Jürgens, Malte Kleinschmidt, Sophy Denker, Moritz Pfeiffer, Belén Millet Pascual-Leone, Luisa Mrziglod, Felix Machleidt, Sebastian Albus, Felix Bremer, Tim Andermann, Carmen Garcia, Philipp Knape, Philipp M. Krause, Liron Lechtenberg, Yaosi Li, Panagiotis Pergantis, Till Jacobi, Teresa Ritter, Berna Yedikat, Lennart Pfannkuch, Christian Zobel, Ute Kellermann, Susanne Fieberg, Laure Bosquillon de Jarcy, Anne Wetzel, Markus C. Brack, Moritz Müller-Plathe, Daniel Zickler, Andreas Edel, Britta Stier, Nils B. Müller, Philipp Enghard, Lucie Kretzler, Lil A. Meyer-Arndt, Linna Li, Isabelle Wirsching, Denise Treue, Dana Briesemeister, Jenny Schlesinger, Daniel Wendisch, Anna L. Hiller, Sophie Brumhard, Christian Frey, Hendrik Müller-Ide, Michael Bauer, Charlotte Thibeault, Florian Kurth, Leif Erik Sander, Tobias Müller, Frank Tacke
Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury
Haoshuang Fu, Zhehan Shen, Rongtao Lai, Tianhui Zhou, Yan Huang, Shuang Zhao, Ruidong Mo, Minghao Cai, Shaowen Jiang, Jiexiao Wang, Bingying Du, Cong Qian, Yaoxing Chen, Fuhua Yan, Xiaogang Xiang, Ruokun Li, Qing Xie
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic
Humberto C. Gonzalez, Faisal M. Nimri, Mei Lu, Yueren Zhou, Loralee B. Rupp, Sheri Trudeau, Stuart C. Gordon
Gut microbiota regulates circadian oscillation in hepatic ischemia–reperfusion injury-induced cognitive impairment by interfering with hippocampal lipid metabolism in mice
Zhigang He, Yanbo Liu, Zhen Li, Tianning Sun, Zhixiao Li, Anne Manyande, Hongbing Xiang, Jun Xiong
Therapeutic role of FNDC5/irisin in attenuating liver fibrosis via inhibiting release of hepatic stellate cell-derived exosomes
Xin Liao, Yilin Luo, Fang Gu, Wen Song, Xin Nie, Qin Yang